Clinical research on bone augmentation with Bio-Oss and B-TCP
Phase 3
- Conditions
- patient planning dental implant surgery with loss of teeth and alveolar bonedental implant
- Registration Number
- JPRN-jRCTs022180044
- Lead Sponsor
- KOYAMA SHIGETO
- Brief Summary
We attempted to compare the clinical evaluation of Bio-Oss, a novel bone replacement material, when used non-approved for dental implants with beta-TCP in existing treatments, but discontinued the study due to noncompliance with the research plan.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 7
Inclusion Criteria
There are taken informed concent among dental implant patients at Tohoku University hospital
Exclusion Criteria
(1) the patients who refsed the consent for this study
(2) the patient judged to be unsuitable for study participation by doctor in charge
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. The amount of bone augmentation<br>2. CT value<br>3. ISQ at implant placement
- Secondary Outcome Measures
Name Time Method prognosis of implant
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms drive Bio-Oss and B-TCP osteoconductive properties in alveolar bone regeneration?
How does Bio-Oss compare to beta-TCP in bone augmentation outcomes for dental implant patients with alveolar bone loss?
Which biomarkers correlate with successful bone healing using Bio-Oss or B-TCP in implant therapy?
What adverse events are associated with Bio-Oss use in non-approved dental implant applications compared to B-TCP?
What alternative bone graft materials or combinations are used in dental implant bone augmentation besides Bio-Oss and B-TCP?